Swedish Cancer Center

The Swedish Cancer Institute (SCI) is a premier cancer care and clinical research center based in Seattle, Washington, and is a division of Swedish Health Services (part of Providence Swedish). Founded in 1932, it was the first dedicated cancer center west of the Mississippi and has grown into one of the most active clinical trial sites in the United States. SCI offers a comprehensive range of oncology services, including advanced cellular therapies like CAR-T, precision medicine guided by genomic sequencing, and innovative surgical techniques. The institute is a key partner for pharmaceutical and biotechnology companies, hosting hundreds of Phase 1-3 clinical trials across nearly all cancer types. With multiple campuses in the Puget Sound region, SCI provides patient-centered care that integrates cutting-edge research with supportive services.